Meet Inaya.

Approaching the age when her late father was diagnosed with Parkinson's disease, Inaya's doctor found a new and promising diagnostic method. Unfortunately, this method has yet to reach the market.

How did the health tech company fast-track their FDA approvals, enabling an early diagnosis for Inaya?

They developed a digital biomarker platform.

Collaborating with Infosys, the health tech company formed a dedicated team of medical device engineers and healthcare domain consultants. They designed a cutting-edge digital biomarker platform that collects keystroke data from personal devices and utilizes an advanced AI/ML algorithm to deliver a comprehensive neurological health score.

This groundbreaking solution has proven beneficial for individuals like Inaya, enabling self-care through preventive measures, all thanks to Infosys.

Discover our approach to fast-tracking FDA approval for swift market entry.

Read on